ASK REDCHAT ANYTHING ABOUT VYNE THERAPEUTICS INC.
VYNE Therapeutics Inc. (NASDAQ: VYNE)
Listen to this Section
$0.66
-0.0140
(
-2.07% )
92.8K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Zilxi (Minocycline)DetailsRosacea |
Approved |
| Amzeeq (minocycline)DetailsAcne vulgaris |
Approved |
| VYN201DetailsVitiligo |
Phase 2b |
| VYN202DetailsPsoriasis, Rheumatoid arthritis |
Phase 1a |
| FMX114 (tofacitinib and fingolimod)DetailsAtopic dermatitis |
Failed |
| FCD105 (minocycline & adapalene)DetailsAcne vulgaris |
Failed |
Market Data
|
| Open |
$0.66 |
| Previous Close |
$0.68 |
| Volume |
92.8K |
| Market Cap |
$22.55M |
| Day Range |
$0.65 - $0.68 |
| 52 Week Range |
$0.28 - $1.96 |
| Shares Outstanding |
33.35M |
| Change % |
-2.07% |
| Net Change |
▼ -0.0140 |
| Insider Ownership |
-0.01% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2018 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-1,058,411.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-01-03 |
Sale |
-20000.00 |
BARBARI SHARON |
| 2024-01-03 |
Sale |
-20000.00 |
Basta Steven L |
| 2024-01-03 |
Sale |
-20000.00 |
Bruno Anthony D |
| 2024-01-03 |
Sale |
-20000.00 |
LEPORE PATRICK G |
| 2024-01-03 |
Sale |
-40000.00 |
Borowski Christine |
| 2024-01-03 |
Sale |
-225000.00 |
Domzalski David |
| 2024-01-03 |
Sale |
-62500.00 |
Stuart Iain |
| 2024-01-03 |
Sale |
-62500.00 |
Zeronda Tyler |
| 2024-01-03 |
Sale |
-62500.00 |
Harsch Mutya |
| 2024-01-03 |
Sale |
-20000.00 |
Sandoval Elisabeth |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| def |
Proxies and info statements |
21 |
Nov 12, 2025 |
| ars |
Annual reports |
1 |
Nov 12, 2025 |
| 8-k |
8K-related |
14 |
Nov 06, 2025 |
| 10-q |
Quarterly Reports |
6 |
Nov 06, 2025 |
| 4 |
Insider transactions |
1 |
Oct 02, 2025 |
| 4 |
Insider transactions |
1 |
Oct 02, 2025 |
| 4 |
Insider transactions |
1 |
Oct 02, 2025 |
| 4 |
Insider transactions |
1 |
Oct 02, 2025 |
| 8-k |
8K-related |
12 |
Sep 12, 2025 |
| 10-q |
Quarterly Reports |
63 |
Aug 14, 2025 |